Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells

Chagas disease (CD), a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi, is an important public health problem mainly in Latin America, leading to approximately 12,000 annual deaths. Current etiological treatment for CD is limited to two nitro compounds, benznidazole (Bz...

Full description

Bibliographic Details
Main Authors:	Juliana Magalhães Chaves Barbosa, Yasmin Pedra-Rezende, Luíza Dantas Pereira, Tatiana Galvão de Melo, Helene Santos Barbosa, Joseli Lannes-Vieira, Solange Lisboa de Castro, Anissa Daliry, Kelly Salomão
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Trypanosoma cruzi Chagas disease amiodarone benznidazole combined treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.975931/full

Similar Items

Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection
by: Juliana Magalhães Chaves Barbosa, et al.
Published: (2022-02-01)

Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
by: Angela Maria Lourenço, et al.

Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
by: Davi Alvarenga Lima, et al.
Published: (2023-05-01)

Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain
by: Edson L.P. Camandaroba, et al.
Published: (2003-04-01)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the <i>Trypanosoma cruzi</i> Strain
by: Kátia da Silva Fonseca, et al.
Published: (2021-06-01)

Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains
by: Veloso VM, et al.
Published: (2001-01-01)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
by: Cristina Vázquez, et al.
Published: (2023-01-01)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2022-07-01)

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
by: Juan Carlos Villar, et al.
Published: (2019-07-01)

Susceptibilidad in vitro a hexadecilfosfocolina (miltefosina), nifurtimox y benznidazole de cepas de Trypanosoma cruzi aisladas en Santander, Colombia
by: Patricia Escobar, et al.
Published: (2009-09-01)

Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol
by: María L. Cafferata, et al.
Published: (2020-08-01)

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV
by: Susana Revollo, et al.
Published: (2019-10-01)

<b>Trypanocidal activity of genotoxic concentration of benznidazole on epimastigote forms of <i>Trypanosoma cruzi</i></b> - 10.4025/actascihealthsci.v34ispec.12337
by: Edilson Nobuyoshi Kaneshima, et al.
Published: (2012-10-01)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
by: Priscila Silva Grijó Farani, et al.
Published: (2021-07-01)

Evaluation of parasitemia by qPCR in patients with chronic Chagas disease treated with benznidazole
by: Bianca Sabaini Pavan Tycha, et al.
Published: (2023-01-01)

Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II) Resposta à quimioterapia com benzonidazol de clones isolados da cepa 21SF do Trypanosoma cruzi (biodema Tipo II, Trypanosoma cruzi II)
by: Rozália Figueira Campos, et al.
Published: (2005-04-01)

Trypanocidal activity of genotoxic concentration of benznidazole on epimastigote forms of Trypanosoma cruzi = Atividade tripanocida da concentração genotóxica do benzonidazol em formas epimastigotas de Trypanosoma cruzi
by: Edilson Nobuyoshi Kaneshima, et al.
Published: (2012-10-01)

A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
by: Bianca Zingales, et al.
Published: (2015-05-01)

Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity
by: Brito TK, et al.
Published: (2020-02-01)

Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice
by: Renata Siqueira Portella, et al.
Published: (2009-11-01)

Acute chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia
by: Martha Lucía Díaz, et al.
Published: (2015-11-01)

Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias
by: Sonia G. Andrade, et al.
Published: (2003-07-01)

Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole
by: Josué Pozo-Martínez, et al.
Published: (2022-03-01)

In vitro and in vivo experimental models for drug screening and development for Chagas disease
by: Alvaro José Romanha, et al.
Published: (2010-03-01)

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
by: Girley Francisco Machado-de-Assis, et al.
Published: (2013-11-01)

The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells
by: Andréia Pires Dantas, et al.
Published: (2006-03-01)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
by: Ana Lia Mazzeti, et al.
Published: (2023-04-01)

Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole
by: Melisa D. Castro Eiro, et al.
Published: (2022-08-01)

Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease
by: Carlos Henrique Valente Moreira, et al.
Published: (2023-09-01)

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against <em>Trypanosoma cruzi</em>
by: Cauê Benito Scarim, et al.
Published: (2021-06-01)

Prostaglandin F2α synthase in Trypanosoma cruzi plays critical roles in oxidative stress and susceptibility to benznidazole
by: Paola García-Huertas, et al.
Published: (2017-01-01)

High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala
by: Lucia Brum-Soares, et al.

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations
by: Douglas de Souza Moreira, et al.
Published: (2018-07-01)

Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes
by: María C. Albareda, et al.
Published: (2018-09-01)

The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi
by: Cristiane França da Silva, et al.
Published: (2010-05-01)

Reações adversas em pacientes com doença de Chagas tratados com benzonidazol, no Estado do Ceará Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará
by: Vânia Maria Oliveira de Pontes, et al.
Published: (2010-04-01)

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
by: Giuliana Muraca, et al.
Published: (2023-07-01)

Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
by: Maria Jose Morilla, et al.
Published: (2005-04-01)

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
by: Leticia L Niborski, et al.
Published: (2016-06-01)